A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
In order to apply human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) to regenerative medicine, the cells should be produced under restricted conditions conforming to GMP guidelines. Since the conventional culture system has some issues that need to be addressed to achieve this goal, we developed a novel culture system. We found that recombinant laminin-511 E8 fragments are useful matrices for maintaining hESCs and hiPSCs when used in combination with a completely xeno-free (Xf) medium, StemFit™. Using this system, hESCs and hiPSCs can be easily and stably passaged by dissociating the cells into single cells for long periods, without any karyotype abnormalities. Human iPSCs could be generated under feeder-free (Ff) and Xf culture systems from human primary fibroblasts and blood cells, and they possessed differentiation abilities. These results indicate that hiPSCs can be generated and maintained under this novel Ff and Xf culture system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The use of defined culture media with recombinant proteins instead of whole animal serum greatly increases process comparability and supply chain assurance [67,68,69].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [68]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Gene-modified therapies, including iPSC-derived products and CAR-T cells, present distinct biosafety and technical challenges for POC implementation (Nakagawa et al., 2014; Moradi et al., 2023).”
From Isolator-based point-of-care manufacturing: a practical solution for GMP-compliant cell and extracellular vesicles therapy production (2025) · cites this paper as Nakagawa et al., 2014
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Self-citationInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Self-citationEmbryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
A more efficient method to generate integration-free human iPS cells
Okita, K., Matsumura, Y., Sato, Y., Okada, A., Morizane, A., Okamoto, S., Hong, H., Nakagawa, M., Tanabe, K., Tezuka, K.-I., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1591 · Cited by 2,061 · cited 3×
“Moreover, hiPSCs were successfully established from primary fibroblasts, peripheral blood and cord blood under these conditions using episomal vectors 16,17 .”
BackgroundMethodA ROCK inhibitor permits survival of dissociated human embryonic stem cells
Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J. B., Nishikawa, S., Nishikawa, S.-I., Muguruma, K., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1310 · Cited by 2,055
Self-citationFeeder-free growth of undifferentiated human embryonic stem cells
Xu, C., Inokuma, M. S., Denham, J., Golds, K., Kundu, P., Gold, J. D., & Carpenter, M. K. (2001) · Nature Biotechnology · doi:10.1038/nbt1001-971 · Cited by 1,870
Chemically defined conditions for human iPSC derivation and culture
Chen, G., Gulbranson, D. R., Hou, Z., Bolin, J. M., Ruotti, V., Probasco, M. D., Smuga-Otto, K., Howden, S. E., Diol, N. R., Propson, N. E., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1593 · Cited by 1,447 · cited 2×
“In addition, it is necessary to use defined culture system for the source of iPS cells, such as fibroblasts or blood cells 13,23 .”
BackgroundMethodEmbryonic stem cell trials for macular degeneration: a preliminary report
Schwartz, S. D., Hubschman, J.-P., Heilwell, G., Franco-Cardenas, V., Pan, C. K., Ostrick, R. M., Mickunas, E., Gay, R., Klimanskaya, I., & Lanza, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60028-2 · Cited by 1,409
Research works printed but not linked: 1
- Grigoriadis, A. E. et al. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood 115, 2769–2776 (2010). · DOI · Paper page
Cited by
Items 401–500 of 675
Hojo, M. A., Tsuzuki, T., Ozawa, Y., Araki, T., & Sakurai, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-11108-5 · Cited by 6
Chaudhary, N., & Villa-Diaz, L. G. (2025) · Frontiers in Toxicology · doi:10.3389/ftox.2025.1667573 · Cited by 10
Kaneko, H., Kaitsuka, T., & Tomizawa, K. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04847-z · Cited by 8
“Therefore, the status of histone marks in the 1383D6 line was tested using its origin of male human dermal fibroblast (HDF) as somatic control to analyze another iPSC line of male origin [27].”
Minami, S., Matsumoto, N., Omori, H., Nakamura, Y., Tamiya, S., Nouda, R., Nurdin, J. A., Yamasaki, M., Kotaki, T., Kanai, Y., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-38548-1 · Cited by 6
Multiplex miRNA reporting platform for real-time profiling of living cells
Hu, Y., Li, C. Y., Lu, Q., & Kuang, Y. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.11.002 · Cited by 7
Tang, J., & Huang, X. (2024) · Gene · doi:10.1016/j.gene.2024.148709 · Cited by 7
Atelocollagen is Promising for Three-Dimensional Culture of Human Induced Pluripotent Stem Cells
Nakashima, Y., & Tsukahara, M. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101302 · Cited by 7
Yoshida, F., Nagatomo, R., Utsunomiya, S., Kimura, M., Shun, S., Kono, R., Kato, Y., Nao, Y., Maeda, K., Koyama, R., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03167-5 · Cited by 9
Nishimoto, S., Mizuno, T., Takahashi, K., Nagano, F., Yuzawa, Y., Nishiyama, A., Osafune, K., Hitomi, H., & Nagamatsu, T. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12800 · Cited by 6
Behl, T., Kaur, I., Sehgal, A., Singh, S., Sharma, N., Chigurupati, S., Felemban, S. G., Alsubaiyel, A. M., Iqbal, M. S., Bhatia, S., et al. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10390-4 · Cited by 6
Kim, M., Thanuthanakhun, N., & Kino‐oka, M. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28285 · Cited by 7
“Cells were routinely cultured in chemically defined and animal component‐free medium (StemFit AK02N; Ajinomoto Co, Inc) on laminin 511‐E8‐coated dishes (iMatrix‐ 511; Nippi, Inc) according to previously published protocols for hiPSC culture (Nakagawa et al., 2015).”
MethodHosokawa, M., Mikawa, R., Hagiwara, A., Okuno, Y., Awaya, T., Yamamoto, Y., Takahashi, S., Yamaki, H., Osawa, M., Setoguchi, Y., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107731 · Cited by 7
“Thawed PBMCs were reprogrammed into iPSC clones with episomal plasmids (pCE-hOCT3/4, pCE-hSK, pCE-hUL, pCE-mp53DD, and pCXB-EBNA1), under feeder-free culture in StemFit AK02Nmedium on iMatrix-511-coated plates (Nippi, Tokyo, Japan) as described previously.(49) The established iPSC clones were cryopreserved in Stem Cel…”
MethodThibaudeau, A., Schmitt, K., François, L., Chatrousse, L., Hoffmann, D., Cousin, L., Weiss, A., Vuidel, A., Jacob, C. B., Sommer, P., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02947-3 · Cited by 9
“The obtained iPSC lines were characterized as previously described (42).”
Stelcer, E., Kulcenty, K. I., Ruciński, M., Jopek, K., Richter, M., Trzeciak, T., & Suchorska, W. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198079 · Cited by 6
Shoji, M., Minato, H., Ogaki, S., Seki, M., Suzuki, Y., Kume, S., & Kuzuhara, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201239 · Cited by 6
Matsuura, K., Wada, M., Sakaguchi, K., Matsuhashi, Y., & Shimizu, T. (2019) · Regenerative Therapy · doi:10.1016/j.reth.2019.04.006 · Cited by 6
Differentiation of Human Pluripotent Stem Cells Into Specific Neural Lineages
Chang, C.-Y., Ting, H.-C., Liu, C.-A., Su, H., Chiou, T., Harn, H., Lin, S., & Ho, T. (2021) · Cell Transplantation · doi:10.1177/09636897211017829 · Cited by 8
Kamiya, D., Takenaka-Ninagawa, N., Motoike, S., Kajiya, M., Akaboshi, T., Zhao, C., Shibata, M., Senda, S., Toyooka, Y., Sakurai, H., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3741231 · Cited by 6
Fukuda, A., Nakashima, S., Oda, Y., Nishimura, K., Kawashima, H., Kimura, H., Ohgita, T., Kawashita, E., Ishihara, K., Hanaki, A., et al. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00797 · Cited by 6
Luo, Y., Xu, Z., & Li, Z. (2025) · FASEB BioAdvances · doi:10.1096/fba.2025-00126 · Cited by 6
Recent advances and applications of human brain models
Nishimura, K., Osaki, H., Tezuka, K., Nakashima, D., Numata, S., & Masamizu, Y. (2024) · Frontiers in Neural Circuits · doi:10.3389/fncir.2024.1453958 · Cited by 5
Regeneration of tracheal epithelium using mouse induced pluripotent stem cells
Ikeda, M., Imaizumi, M., Yoshie, S., Otsuki, K., Miyake, M., Hazama, A., Wada, I., & Omori, K. (2016) · Acta Oto-Laryngologica · doi:10.3109/00016489.2015.1121548 · Cited by 5
“The removal of animal-derived products from the process of cell culture, and the induction of differentiation without the use of feeder cells or serum-containing culture media are also required [20].”
BackgroundGeneration of a TALEN-mediated, p63 knock-in in human induced pluripotent stem cells
Kobayashi, Y., Hayashi, R., Quantock, A. J., & Nishida, K. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.10.015 · Cited by 8
Yamashita, T., Kamiya, D., Kawaraichi, N., Toyokawa, H., Akaboshi, T., Ikeya, M., & Toyooka, Y. (2022) · Stem Cell Research · doi:10.1016/j.scr.2022.102696 · Cited by 5
Masuzawa, Y., & Kitazawa, M. (2022) · Materials · doi:10.3390/ma15103687 · Cited by 5
“We followed the Center for iPS Cell Research and Application’s standard instructions for transferring hiPSCs from a feeder to a feeder-free culture [9].”
BackgroundMethodSemi-3D cultures using Laminin 221 as a coating material for human induced pluripotent stem cells
Nakashima, Y., Yoshida, S., & Tsukahara, M. (2022) · Regenerative Biomaterials · doi:10.1093/rb/rbac060 · Cited by 6
Shigyo, M., Kobayashi, Y., Platoshyn, O., Marsala, S., Kato, T., Takamura, N., Yoshida, K., Kishino, A., Bravo‐Hernández, M., Juhás, Š., et al. (2023) · Cell Transplantation · doi:10.1177/09636897231163232 · Cited by 5
“Repro-gramming was performed under feeder-free (FF)/xeno-free (XF) condition 35 .”
MethodMizuno, K., Ohnishi, H., Yoshimatsu, M., Zhao, C., Hayashi, Y., Kuwata, F., Kaba, S., Okuyama, H., Kawai, Y., Hiwatashi, N., et al. (2023) · Cell Transplantation · doi:10.1177/09636897231178460 · Cited by 5
Sugiyama‐Nakagiri, Y., Yamashita, S., Taniguchi, Y., Shimono, C., & Sekiguchi, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-41701-5 · Cited by 5
When Myc's asleep, embryonic stem cells are dormant
Nakagawa, M., Karagiannis, P., & Yamanaka, S. (2016) · The EMBO Journal · doi:10.15252/embj.201694095 · Cited by 5
“Like c-Myc, L-Myc is an important factor for iPSC generation especially for human iPSCs, as the efficiency of human iPSC generation is higher with L-Myc than with c-Myc and reduces the risk of tumorigenesis (Nakagawa et al , 2010, 2014).”
Ishihara, K., Ichinomiya, A., Inami, M., Hashimoto, T., Yuzawa, R., Ishizu, M., Hirohara, T., Yashiro, Y., & Takizawa, T. (2016) · Regenerative Therapy · doi:10.1016/j.reth.2016.09.003 · Cited by 5
“Although fibroblasts were originally used the somatic cells for the preparation of iPS cells [1e3], modified methods utilizing while blood cells [11] and a feeder-free culture system [12] have been established for use in medical treatment.”
MethodYamamoto‐Shimojima, K., Osawa, M., Saito, M. K., & Yamamoto, T. (2020) · Congenital Anomalies · doi:10.1111/cga.12403 · Cited by 5
“Then, iPSCs were established as described previously.(4,5) We verified that established iPSCs showed typical pluripotent stem cell-like morphology, maintained a normal karyotype, and expressed comparable levels of pluripotency-associated genes (NANOG and OCT4) compared with those in a control iPSC line.”
ResultSoeda, S., Saito, R., Fujii, A., Tojo, S., Tokumura, Y., & Taniura, H. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102351 · Cited by 5
Grinand, L., & Takahashi, J. (2022) · Regenerative Therapy · doi:10.1016/j.reth.2022.01.002 · Cited by 5
Nakano, Y., Susa, K., Yanagi, T., Hiraoka, Y., Suzuki, T., Mori, T., Ando, F., Mandai, S., Fujiki, T., Rai, T., et al. (2022) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-022-00655-0 · Cited by 6
“com/) (Nakagawa et al. 2014), and authenticated by short tandem repeat analysis.”
MethodYamada, D., Takao, T., Nakamura, M., Kitano, T., Nakata, E., & Takarada, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052661 · Cited by 5
“However, methods must be established to assess and increase the purity of differentiated cells to avoid teratoma formation in vivo [24].”
MethodElucidation of HHEX in pancreatic endoderm differentiation using a human iPSC differentiation model
Ito, R., Kimura, A., Hirose, Y., Hatano, Y., Mima, A., Mae, S.-I., Keidai, Y., Nakamura, T., Fujikura, J., Nishi, Y., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-35875-1 · Cited by 6
Defects in early synaptic formation and neuronal function in Prader-Willi syndrome
Soeda, S., Ito, D., Ogushi, T., Sano, Y., Negoro, R., Fujita, T., Saito, R., & Taniura, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-39065-x · Cited by 5
Suzuki, T., Susa, K., Kikuchi, H., Nakano, Y., Yanagi, T., Hara, Y., Fujiki, T., Ando, F., Mandai, S., Mori, Y., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04567-0 · Cited by 5
“Human iPSC 1231A3 was provided by the RIKEN BRC through the National Bio Resource Project of the MEXT, Japan [18], and we generated NPHP1 −/− iPSCs as reported [17].”
An N-terminal CDC42 T43I variant reveals the mechanism of pyrin inflammasome activation
Aoki, M., Iannuzzo, A., Mertz, P., Feng, S., Iwata, N., Perugini, C., Tsuchida, N., Masri, R. E., Kuchitsu, Y., Tacine, R., et al. (2026) · Science Immunology · doi:10.1126/sciimmunol.aea0515 · Cited by 4
Kim, M., Thanuthanakhun, N., & Kino‐oka, M. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1269108 · Cited by 5
Takagi, D., Tsukamoto, S., Nakade, K., Shimizu, T., Arai, Y., Matsuo‐Takasaki, M., Noguchi, M., Nakamura, Y., Yumoto, N., Kawada, J., et al. (2024) · Stem Cell Research · doi:10.1016/j.scr.2024.103493 · Cited by 5
Sueyoshi, M., Harada, K., Okawa, M., Matsuhara, T., Ando, M., Araki, R., Minote, Y., Ishihara, K., Shimohama, S., & Takata, K. (2025) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b25-00308 · Cited by 6
Lu, X., Perr, E., Naqvi, T., Galitz, D., Andersen, M., Grabowski, D. C., Person, A. D., Kalyuzhny, A. E., & Flynn, K. C. (2024) · Cells · doi:10.3390/cells13181566 · Cited by 5
Yamasaki, M., Maki, T., Mochida, T., Hamada, T., Watanabe-Matsumoto, S., Konagaya, S., Kaneko, M., Ito, R., Ueno, H., & Toyoda, T. (2024) · Cell Transplantation · doi:10.1177/09636897241288932 · Cited by 4
“QHJ-I14s04, an HLA-homozygous iPSC line, was established as previously described 16 .”
MethodiPSC screening identifies CACNA2D2 as a potential therapeutic target for FTLD-Tau
Imamura, K., Nagahashi, A., Okusa, A., Sakasai, T., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Sahara, N., Kanaan, N. M., et al. (2025) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2025.151484 · Cited by 4
Fujiwara, N., Uno, M., Fukuda, H., Nagakubo, A., Tan, S., Kino‐oka, M., & Ogi, H. (2025) · Physical Review X · doi:10.1103/physrevx.15.021015 · Cited by 4
MDM4 enables efficient human iPS cell generation from PBMCs using synthetic RNAs
Nakagawa, M., Nogi, M., Doi, H., Hayashi, R., Katayama, T., Ohno, H., Mochizuki, M., Hayashi, K., & Saito, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-16446-y · Cited by 5
“The bFGF(-) culture condition promotes spontaneous differentiation into ectoderm, mesoderm, and endoderm lineages, as demonstrated in previous work 7 .”
InfluentialEngineering Niches for Embryonic and Induced Pluripotent Stem Cells
Mao, H., & Ito, Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802734-9.00028-7 · Cited by 4
Nandal, A., Mallon, B. S., & Telugu, B. P. V. L. (2017) · Journal of Visualized Experiments · doi:10.3791/56260 · Cited by 5
Sato, Y., Yamada, T., Hiroyama, T., Sudo, K., Hasegawa, N., Hyodo, I., & Nakamura, Y. (2019) · Cancer Science · doi:10.1111/cas.13978 · Cited by 6
Alternating electric field application induced non-contact and enzyme-free cell detachment
Koyama, S., Wada, M., Tamura, Y., Ishikawa, G., Kobayashi, J., & Ishikawa, Y. (2019) · Cytotechnology · doi:10.1007/s10616-019-00307-4 · Cited by 4
Ura, H., Togi, S., Hatanaka, H., & Niida, Y. (2022) · Stem Cell Research · doi:10.1016/j.scr.2022.102867 · Cited by 4
A Non‐Destructive Electrical Assay of Stem Cell Differentiation Based on Semiconductor Biosensing
Hideshima, S., Hayashi, H., Saito, S., Tateno, H., Momma, T., & Ōsaka, T. (2022) · Analysis & Sensing · doi:10.1002/anse.202200046 · Cited by 4
Takamura, T., Nagashima, H., Matsunari, H., Yamanaka, S., Saito, Y., Kinoshita, Y., Fujimoto, T., Matsumoto, K., Nakano, K., Okano, H. J., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11237237 · Cited by 4
Qian, E., Uemura, M., Kobayashi, H., Nakamura, S., Ozawa, F., Yoshimatsu, S., Ishikawa, M., Onodera, O., Morimoto, S., & Okano, H. (2023) · Inflammation and Regeneration · doi:10.1186/s41232-023-00273-7 · Cited by 6
“For iPSC establishment, peripheral blood mononuclear cells (PBMCs) from the patient were reprogrammed by electroporation of episomal vectors (pCE-hOCT3/4, pCE-hSK, pCE-hUL, pCE-mp53DD, and pCXB-EBNA1) [20], and cultured in feeder-free and on-feeder conditions.”
MethodPreclinical Research of Stem Cells: Challenges and Progress
Li, J., Wu, Y., Xiang, Y., Tian, Y., Sun, X., Liu, Z., Ye, X., & Wu, C. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10528-y · Cited by 4
Ura, H., Togi, S., Hatanaka, H., & Niida, Y. (2024) · Stem Cell Research · doi:10.1016/j.scr.2024.103388 · Cited by 4
Suga, M., Kondo, T., Imamura, K., Shibukawa, R., Okanishi, Y., Sagara, Y., Tsukita, K., Enami, T., Furujo, M., Saijo, K., et al. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101406 · Cited by 4
“The selected iPSC clone was expanded and maintained using StemFit medium and iMatrix-511 E8 fragment (Nakagawa et al., 2014).”
MethodNatarajan, M., Singh, P., Mondal, T., Kumar, K., Das, K., Dutt, T., & Bag, S. (2021) · Tissue and Cell · doi:10.1016/j.tice.2021.101571 · Cited by 4
Zhou, Z., Kakegawa, W., Fujimori, K., Sho, M., Shimamura, R., Supakul, S., Yoshimatsu, S., Kohyama, J., Yuzaki, M., & Okano, H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.10.528087 · Cited by 6
“Results Efficient induction of neural progenitors with a cerebrocortical identity from feeder-free human iPS cells Initially, we sought to devise an optimized induction method of SOX1(+) incipient ectodermal cells from 201B7 healthy-control human iPS cells [6] cultured in a feeder-free condition using AK02N as a cultu…”
BackgroundMethodInfluentialActin polymerization drives lumen formation in a human epiblast modelPreprint
Indana, D., Zakharov, A. P., Lim, Y., Dunn, A. R., Bhutani, N., Shenoy, V. B., & Chaudhuri, O. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.20.537711 · Cited by 4
“Nuclear area and perimeter: Nuclear area and perimeter of synthetic and human epiblasts as well as hiPSCs in 2D culture, were respectively measured from immunostained images acquired in-house and from previously published sources (Deglincerti et al., 2016; Molè et al., 2021; Nakagawa et al., 2014; Rodin et al., 2010;…”
MethodInter-cellular mRNA Transfer Alters Human Pluripotent Stem Cell StatePreprint
Yoneyama, Y., Zhang, R., Kimura, M., Cai, Y., Adam, M., Parameswaran, S., Masaki, H., Mizuno, N., Bhadury, J., Maezawa, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.27.600209 · Cited by 4
Zehra, B., Mohamed, N., Farhat, A., Bru‐Mercier, G., Satsangi, D., Tambi, R., Kamarudheen, R., Kumail, M., Khalil, R., Pessia, M., et al. (2024) · Journal of Neurophysiology · doi:10.1152/jn.00045.2024 · Cited by 3
Yang, K., Yuan, S., Wang, Y., An, L., Huo, F., Jin, Z., Yang, C., & Tian, W. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1717849 · Cited by 5
Integrin Signaling and ECM Proteins in hPSC Maintenance and Differentiation
Wei, T., & Wang, Z. Z. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl46332 · Cited by 5
Yamashita, D., Hamano, S., Hasegawa, D., Sugii, H., Itoyama, T., Ikeya, M., & Maeda, H. (2024) · Stem Cells and Development · doi:10.1089/scd.2024.0122 · Cited by 3
Kim, M., Kuroda, M., Ke, D., Thanuthanakhun, N., & Kino‐oka, M. (2023) · Journal of Biological Engineering · doi:10.1186/s13036-023-00341-z · Cited by 3
Ura, H., Togi, S., Ozaki, M., Hatanaka, H., & Niida, Y. (2023) · Stem Cell Research · doi:10.1016/j.scr.2023.103129 · Cited by 3
Canine induced pluripotent stem cells can be successfully maintained in weekend-free culture systems
Kimura, K., NAGAKURA, H., Tsukamoto, M., YOSHIDA, T., Sugisaki, H., Shishida, K., TACHI, Y., SHIMASAKI, S., Sugiura, K., & Hatoya, S. (2024) · Journal of Veterinary Medical Science · doi:10.1292/jvms.23-0422 · Cited by 4
“In contrast, our group showed that a serum-and feeder-free culture system for human pluripotent stem cells (hPSCs) using StemFit AK02N [ 35] as a medium and laminin-511 E8-fragment (commercial name iMatrix-511) [ 34 ] as a coating matrix can be used to culture ciPSCs [ 22].”
Oonishi, T., Nishimura, K., Takata, K., Fujimuro, M., & Sekine, Y. (2024) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b23-00675 · Cited by 3
Tsukamoto, M., Kawasaki, T., Vemuri, M. C., Umezawa, A., & Akutsu, H. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2024.02.005 · Cited by 3
Robust differentiation of human pluripotent stem cells into Schwann cells
Tooi, N., Okama, R., Sato, H., Inose, H., Ogasawara, H., Senda, H., Nakatsuji, N., Kato, K., Kiboku, T., & Igura, K. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150353 · Cited by 3
Rat Tracheal Cartilage Regeneration Using Mesenchymal Stem Cells Derived From Human iPS Cells
Mizuno, K., Ohnishi, H., Kishimoto, Y., Kojima, T., Fujimura, S., Kawai, Y., Kitano, M., Ikeya, M., & Omori, K. (2024) · Tissue Engineering Part A · doi:10.1089/ten.tea.2024.0151 · Cited by 3
Laminin 511 E8 fragment promotes to form basement membrane-like structure in human skin equivalents
Fujisaki, H., Watanabe, T., Yoshihara, S., Fukuda, H., Tomono, Y., Tometsuka, C., Mizuno, K., Nishiyama, T., & Hattori, S. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2024.08.014 · Cited by 3
Li, R., Tsuboi, H., Ito, H., Takagi, D., Chang, Y.-H., Shimizu, T., Arai, Y., Matsuo‐Takasaki, M., Noguchi, M., Nakamura, Y., et al. (2024) · Stem Cell Research · doi:10.1016/j.scr.2024.103584 · Cited by 3
Ge, N., Suzuki, K. H., Sato, I., Noguchi, M., Nakamura, Y., Matsuo‐Takasaki, M., Fujishiro, J., & Hayashi, Y. (2024) · Human Cell · doi:10.1007/s13577-024-01147-x · Cited by 4
Katagami, Y., Kondo, T., Suga, M., Yada, Y., Imamura, K., Shibukawa, R., Sagara, Y., Okanishi, Y., Tsukita, K., Hirayama, K., et al. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.102095 · Cited by 3
At the Conflux of Human Genome Engineering and Induced Pluripotency
Woltjen, K., Oceguera-Yañez, F., Kagawa, H., & Kim, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-34148-4_3 · Cited by 3
The application of iPSCs in Parkinson’s disease
Nielsen, J. J. J., Lillethorup, T. P., Glud, A. N., Sørensen, J. C. H., & Orłowski, D. (2020) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2020-024 · Cited by 3
“…e.g., DA neurons (Takahashi and Yamanaka, 2006; Stanslowsky et al., 2014) but direct neuronal conversion of fibroblasts into DA neurons in vitro and in vivo is possible with only three transcrip‑ tion factors: Asc11, Brn2 and Myt1l (Vierbuchen et al., 2010; Liu et al., 2012, Nakagawa et al., 2014).”
BackgroundGeneration of Motor Neurons from Human ESCs/iPSCs Using Sendai Virus Vectors
Imamura, K., Kawaguchi, J., Shu, T., & Inoue, H. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1601-7_9 · Cited by 4
Human serum albumin-containing xeno-free freezing medium optimized for regenerative medicine
Bamba, K., Ozawa, M., Tamai, M., Shimbo, E., Shindo, H., Takuo, O. T. A., Ahn, S., Kohara, A., & Tagawa, Y. (2021) · Translational and Regulatory Sciences · doi:10.33611/trs.2021-008 · Cited by 3
Hossain, M. A., Hasegawa-Ogawa, M., Manome, Y., Igarashi, M., Wu, C., Suzuki, K., Igarashi, J., Iwamoto, T., Okano, H. J., & Eto, Y. (2022) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2022.100852 · Cited by 3
MYCL promotes iPSC-like colony formation via MYC Box 0 and 2 domains
Akifuji, C., Iwasaki, M., Kawahara, Y., Sakurai, C., Cheng, Y.-S., Imai, T., & Nakagawa, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-03260-5 · Cited by 3
Sone, T., Shin, M., Ouchi, T., Sasanuma, H., Miyamoto, A., Ohte, S., Tsukamoto, S., Nakanishi, M., Okano, H., Katagiri, T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46105-y · Cited by 3
Induced Pluripotent Stem Cells in Scaffold‐Based Tissue Engineering
Rana, D., Thacker, M., Leena, M. M., & Ramalingam, M. (2017) · Wiley eBooks · doi:10.1002/9783527689934.ch4 · Cited by 3
The future: Stem cells? Current clinical trials using stem cells for dopaminergic cell replacement
Paul, G., Morizane, A., Kirkeby, A., Takahashi, J. B., & Henchcliffe, C. (2024) · International review of movement disorders · doi:10.1016/bs.irmvd.2024.08.004 · Cited by 3
Development of a Xeno-Free Substrate for Human Embryonic Stem Cell Growth
Zhu, H., Yang, J., Wei, Y., & Chen, H. H. (2015) · Stem Cells International · doi:10.1155/2015/621057 · Cited by 2
“For clinic applications, several different kinds of xenofree substrates have been developed in recent years, such as human feeder cells [4, 5], vitronectin [6–8], laminin [9], RGD peptide [10], and human placenta derived ECM [11].”
BackgroundiPS cells from Chediak‐Higashi syndrome patients recapitulate the giant granules in myeloid cells
Oh, S., Niwa, A., Nagahashi, A., Asaka, I., Nakahata, T., & Saito, M. K. (2022) · Pediatrics International · doi:10.1111/ped.15390 · Cited by 3
Xu, W., Wang, J., Li, W., Gao, L., Hao, R., Han, X., Li, C., Zhang, H., & Li, X. (2022) · Theriogenology · doi:10.1016/j.theriogenology.2022.10.042 · Cited by 2
Pathophysiology and Management Approaches for Parkinson’s Disease
Khan, S. S., Naren, P., Pinjala, P., Uppala, S. N., Singh, S. B., & Khatri, D. K. (2023) · Springer eBooks · doi:10.1007/978-981-99-6807-7_5 · Cited by 3
Fujiwara, N., Matsumoto, T., Nagakubo, A., Tan, S., Kino‐oka, M., & Ogi, H. (2025) · npj Biological Physics and Mechanics. · doi:10.1038/s44341-024-00004-0 · Cited by 2
Generation and characterization of induced pluripotent stem cells of small apes
Hamazaki, Y., Akuta, H., Suzuki, H., Tanabe, H., Ichiyanagi, K., Imamura, T., & Imamura, M. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1536947 · Cited by 2
Sogabe, S., Nakano, H., Ogasahara, Y., Cha, P.-C., Ando, Y., Taniguchi‐Ikeda, M., Matsumoto, R., Kanagawa, M., Kobayashi, K., Murayama, S., et al. (2025) · Journal of Human Genetics · doi:10.1038/s10038-025-01335-z · Cited by 4
Matsuzono, K., Honda, H., Mashiko, T., Koide, R., Sakashita, E., Endo, H., Kitamoto, T., & Fujimoto, S. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05698-6 · Cited by 2
Ohno, H., Nishimura, T., Kainoh, K., Ohashi, Y., Onodera, N., Kano, M., Sari, L. N., Masuda, M., Tamura, Y., Nishino, T., et al. (2026) · The FEBS Journal · doi:10.1111/febs.70286 · Cited by 2
Kyoto hESC cell resource for regenerative medicine
Kawase, E., Takada, K., & Suemori, H. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.102020 · Cited by 4
Induced Pluripotent Stem Cells for Clinical Use
Seki, T., & Fukuda, K. (2016) · InTech eBooks · doi:10.5772/62505 · Cited by 3
“There have been many subsequent reports of xeno-free media such as TeSR2 [37], NutriStem [38], Essential E8 [34], and StemFit [39] for human iPSC generation and maintaining.”
BackgroundInduced Pluripotent Stem Cells and Cartilage Regeneration
Diederichs, S., & Richter, W. (2017) · Springer eBooks · doi:10.1007/978-3-319-53316-2_4 · Cited by 3
Yada, Y., Kondo, T., Suga, M., Tsukita, K., Enami, T., Shibukawa, R., Sagara, Y., Okanishi, Y., Imamura, K., Kihara, T., et al. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102274 · Cited by 2
Metadata
- Authors
- Nakagawa, M., Taniguchi, Y., Senda, S., Takizawa, N., Ichisaka, T., Asano, K., Morizane, A., Doi, D., Takahashi, J., Nishizawa, M., Yoshida, Y., Toyoda, T., Osafune, K., Sekiguchi, K., & Yamanaka, S.
- Affiliations
- Kyoto University (JP)
- Institute for Protein Research, The University of Osaka (JP)
- Ajinomoto (Japan) (JP)
- Gladstone Institutes (US)
- Corresponding author
- Nakagawa, Masato
- ORCID
- Venue
- Scientific Reports
- Published
- 2014-01-08
- Volume
- 4
- Issue
- 1
- Pages
- 3594-3594
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC3884228
- OpenAlex
- W1972564906
- Cited by
- 673
- References
- 30
- Citations by year
- 2026: 35 · 2025: 46 · 2024: 74 · 2023: 66 · 2022: 65 · 2021: 76 · 2020: 66 · 2019: 49 · 2018: 37 · 2017: 58 · 2016: 47 · 2015: 39 · 2014: 14
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- OUKA (Osaka University Knowledge Archive) (Osaka University) (submittedVersion)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion, cc-by-nc-nd)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science (25860747, 24790277, 24590353, 24592124, 25291026)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- induced pluripotent stem cells, feeder-free culture, xeno-free culture, human embryonic stem cells, primary fibroblasts, blood cells, karyotype stability, cell dissociation, differentiation potential
- MeSH terms
- Cell Differentiation, Culture Media, Humans, Serial Passage, Cell Culture Techniques, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.